Global Gene Synthesis Market Size, Share, Opportunities, And Trends By Type (Gene Library Synthesis, Custom Gene Synthesis), By Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutic Antibodies, Others), By End Users (Pharmaceuticals and Biopharmaceutical Companies, Contract Research Organisations, Research Institutes) And By Geography - Forecasts From 2025 To 2030

Gene Synthesis Market Size:

The Gene Synthesis Market will surge from USD 2.304 billion in 2025 to USD 5.234 billion by 2030, fueled by a 17.83% CAGR.

Gene synthesis refers to the chemical, base-by-base in vitro synthesis of double-stranded DNA sequence that represents one or more genes. The technology has become a significant tool in in the areas of vaccine development, gene therapy, molecular engineering, and in development of recombinant DNA. Gene synthesis have also introduced the possibility of developing genes containing modified nucleotides or even novel base pairs that could allow for the expansion of the genetic code. The growth in the market may be attributed to the increasing investment in research and development in the field of genomics and next generation sequencing. Increasing Government interest and funding in the field of genomics will also positively impact the market. However, high cost and complexity of the gene synthesis techniques might hamper the growth of the market. Dearth of skilled professionals for the techniques might also restrain the market for gene synthesis during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Gene Synthesis market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Gene Synthesis market.

Major industry players profiled as part of the report are Evonetix, Genewiz and ATUM among others.

Segmentation

By Type

Gene Library Synthesis

Custom Gene Synthesis

 

By Application

Synthetic Biology

Genetic Engineering

Vaccine Design

Therapeutic Antibodies

Others

 

By End Users

Pharmaceuticals and Biopharmaceutical Companies

Contract Research Organisations

Research Institutes

 

By Geography

North America

United States

Canada

Others

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Others

 

 

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

 

Asia Pacific

China

India

Australia

South Korea

Others

Thermo Fisher Scientific

Genewiz

Gesncript Inc.

Eurofins Genomics

ATUM

Synbio Technologies

Epoch Life Science Inc. 

GCC Biotech (India) Pvt. Ltd.

Evonetix

Twist Bioscience